Journal of Pediatrics Review

Published by: Kowsar

Type 1 Diabetes Mellitus Associated With Autoimmune Thyroid Disorders in Iranian Children: A Review

Daniel Zamanfar 1 , Mohsen Aarabi 2 , * and Iman Sadeghian 3
Authors Information
1 Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Health Sciences Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Journal of Pediatrics Review: January 31, 2015, 3 (1); e157
  • Published Online: January 20, 2015
  • Article Type: Review Article
  • Received: November 8, 2014
  • Accepted: December 30, 2014
  • DOI: 10.5812/jpr.157

To Cite: Zamanfar D, Aarabi M, Sadeghian I. Type 1 Diabetes Mellitus Associated With Autoimmune Thyroid Disorders in Iranian Children: A Review, J Pediatr Rev. 2015 ;3(1):e157. doi: 10.5812/jpr.157.

Copyright © 2015, Mazandaran University of medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 Suppl 1-9[DOI][PubMed]
  • 2. Ghawil M, Tonutti E, Abusrewil S, Visentini D, Hadeed I, Miotti V, et al. Autoimmune thyroid disease in Libyan children and young adults with type 1 diabetes mellitus. Eur J Pediatr. 2011; 170(8): 983-7[DOI][PubMed]
  • 3. Li L, Shen S, Ouyang J, Hu Y, Hu L, Cui W, et al. Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves beta-cell function in Chinese patients with new onset of type 1 diabetes. J Clin Endocrinol Metab. 2012; 97(5): 1729-36[DOI][PubMed]
  • 4. Black MM, Quigg AM, Hurley KM, Pepper MR. Iron deficiency and iron-deficiency anemia in the first two years of life: strategies to prevent loss of developmental potential. Nutr Rev. 2011; 69 Suppl 1-70[DOI][PubMed]
  • 5. Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr. 1981; 99(3): 350-4[PubMed]
  • 6. Radaideh A, El-Khateeb M, Batieha AM, Nasser AS, Ajlouni KM. Thyroid function and thyroid autoimmunity in patients with type 1 diabetes mellitus. Saudi Med J. 2003; 24(4): 352-5[PubMed]
  • 7. Prazny M, Skrha J, Limanova Z, Vanickova Z, Hilgertova J, Prazna J, et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol Res. 2005; 54(1): 41-8[PubMed]
  • 8. Hawkins BR, Cheah PS, Dawkins RL, Whittingham S, Burger HG, Patel Y, et al. Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet. 1980; 2(8203): 1057-9[PubMed]
  • 9. Menon PS, Vaidyanathan B, Kaur M. Autoimmune thyroid disease in Indian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001; 14(3): 279-86[PubMed]
  • 10. Holl RW, Bohm B, Loos U, Grabert M, Heinze E, Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Horm Res. 1999; 52(3): 113-8[PubMed]
  • 11. Chikuba N, Akazawa S, Yamaguchi Y, Kawasaki E, Takino H, Takao Y, et al. Type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune thyroid disease in Japan. Intern Med. 1992; 31(9): 1076-80[PubMed]
  • 12. Barker JM. Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006; 91(4): 1210-7[DOI][PubMed]
  • 13. Tuomilehto J, Podar T, Tuomilehto-Wolf E, Virtala E. Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents. Diabetologia. 1995; 38(8): 975-82[PubMed]
  • 14. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009; 360(16): 1646-54[DOI][PubMed]
  • 15. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab. 2004; 89(8): 3896-902[DOI][PubMed]
  • 16. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994; 371(6493): 130-6[DOI][PubMed]
  • 17. Mohn A, Di Michele S, Di Luzio R, Tumini S, Chiarelli F. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabet Med. 2002; 19(1): 70-3[PubMed]
  • 18. Frohlich-Reiterer EE, Kaspers S, Hofer S, Schober E, Kordonouri O, Pozza SB, et al. Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease. J Pediatr. 2011; 158(4): 589-593 e2[DOI][PubMed]
  • 19. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36(4): 337-8[DOI][PubMed]
  • 20. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004; 53(11): 3020-3[PubMed]
  • 21. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994; 331(21): 1428-36[DOI][PubMed]
  • 22. Boitard C. The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects. Diabetologia. 1992; 35(12): 1101-12[PubMed]
  • 23. Lendrum R, Walker G, Gamble DR. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet. 1975; 1(7912): 880-2[PubMed]
  • 24. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007; 104(43): 17040-5[DOI][PubMed]
  • 25. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature. 2005; 435(7039): 220-3[DOI][PubMed]
  • 26. Greenbaum CJ, Wilkin TJ, Palmer JP. Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories. Diabetologia. 1992; 35(8): 798-800[PubMed]
  • 27. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol. 1994; 152(6): 3183-8[PubMed]
  • 28. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest. 2004; 114(4): 589-97[DOI][PubMed]
  • 29. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990; 347(6289): 151-6[DOI][PubMed]
  • 30. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 2001; 50(11): 2451-8[PubMed]
  • 31. Ellis TM, Schatz DA, Ottendorfer EW, Lan MS, Wasserfall C, Salisbury PJ, et al. The relationship between humoral and cellular immunity to IA-2 in IDDM. Diabetes. 1998; 47(4): 566-9[PubMed]
  • 32. Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, et al. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab. 2010; 95(10): 4712-9[DOI][PubMed]
  • 33. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 1996; 45(7): 926-33[PubMed]
  • 34. Kukko M, Kimpimaki T, Korhonen S, Kupila A, Simell S, Veijola R, et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab. 2005; 90(5): 2712-7[DOI][PubMed]
  • 35. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 1994; 43(11): 1304-10[PubMed]
  • 36. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997; 46(11): 1701-10[PubMed]
  • 37. Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF, et al. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care. 1999; 22(12): 2049-54[PubMed]
  • 38. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003; 423(6939): 506-11[DOI][PubMed]
  • 39. Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, et al. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet. 2003; 11(1): 81-4[DOI][PubMed]
  • 40. Sumnik Z, Drevinek P, Snajderova M, Kolouskova S, Sedlakova P, Pechova M, et al. HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2003; 16(6): 851-8[PubMed]
  • 41. Karavanaki K, Kakleas K, Paschali E, Kefalas N, Konstantopoulos I, Petrou V, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res. 2009; 71(4): 201-6[DOI][PubMed]
  • 42. Kordonouri O, Charpentier N, Hartmann R. GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis. Pediatr Diabetes. 2011; 12(1): 31-3[DOI][PubMed]
  • 43. Katahira M, Maeda H, Tosaki T, Segawa S. The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population. Diabetes Res Clin Pract. 2009; 85(3): 293-7[DOI][PubMed]
  • 44. Beaven DW, Nelson DH, Renold AE, Thorn GW. Diabetes mellitus and Addison's disease: a report on eight patients and a review of 55 cases in the literature. N Engl J Med. 1959; 261: 443-54[DOI][PubMed]
  • 45. Okten A, Akcay S, Cakir M, Girisken I, Kosucu P, Deger O. Iodine status, thyroid function, thyroid volume and thyroid autoimmunity in patients with type 1 diabetes mellitus in an iodine-replete area. Diabetes Metab. 2006; 32(4): 323-9[PubMed]
  • 46. Kalicka-Kasperczyk A, Dziatkowiak H, Bartnik-Mikuta A, Pituch-Noworolska A, Kasperczyk K, Nazim J, et al. [Thyroid peroxidase antibodies and thyroid diseases in children and adolescents with newly diagnosed type I diabetes]. Przegl Lek. 2002; 59(7): 509-13[PubMed]
  • 47. Norden G, Jensen E, Stilbo I, Bottazzo GF, Lernmark A. B-cell function and islet cell and other organ-specific autoantibodies in relatives to insulin-dependent diabetic patients. Acta Med Scand. 1983; 213(3): 199-203[PubMed]
  • 48. Mantovani RM, Mantovani LM, Dias VM. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: prevalence and risk factors. J Pediatr Endocrinol Metab. 2007; 20(6): 669-75[PubMed]
  • 49. Gonzalez GC, Capel I, Rodriguez-Espinosa J, Mauricio D, de Leiva A, Perez A. Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction. Diabetes Care. 2007; 30(6): 1611-2[DOI][PubMed]
  • 50. Leong KS, Wallymahmed M, Wilding J, MacFarlane I. Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes. Postgrad Med J. 1999; 75(886): 467-70[PubMed]
  • 51. Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabet Med. 2002; 19(6): 518-21[PubMed]
  • 52. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care. 2002; 25(8): 1346-50[PubMed]
  • 53. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005; 28(1): 186-212[PubMed]
  • 54. Chase HP, Garg SK, Cockerham RS, Wilcox WD, Walravens PA. Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet Med. 1990; 7(4): 299-303[PubMed]
  • 55. Shiva S, Ilkhchooyi F, Shiva S, Rezamand A. Thyroid autoimmunity at the onset of type 1 diabetes mellitus in children. Open J Immun. 2013; 3(1): 37-40[DOI]
  • 56. Sharifi F, Ghasemi L, Mousavinasab N. Thyroid function and anti-thyroid antibodies in Iranian patients with type 1 diabetes mellitus: influences of age and sex. Iran J Allergy Asthma Immunol. 2008; 7(1): 31-6[PubMed]
  • 57. Bahrami A. [Autoimmune Thyroid Disorders in Patients with Type 1 Diabetes Mellitus; Results of Long Term Follow up of a Large Cohort of Patients in Endocrine and Diabetes Clinics of Tabriz University of Medical Sciences]. Med J Tabriz Univ Med Sci. 2012; 34: 22-7
  • 58. Saffari F, Asgari A, Sadeghi T, Hajmanouchehri F. [Comparison of Hashimoto thyroiditis in patients with type 1 diabetes and controls]. J Qazvin Univ Med Sci. 2011; 15(2): 86-93
  • 59. Vakili R, Mahmoudi M, Ghasemi A. Prevalence of thyroid autoantibodies in diabetic children and adolescents in mashhad. Iran J Diabetes Metabol. 2004; 3(1): 7-11
  • 60. Ardestani SK, Keshteli AH, Khalili N, Hashemipour M, Barekatain R. Thyroid disorders in children and adolescents with type 1 diabetes mellitus in isfahan, iran. Iran J Pediatr. 2011; 21(4): 502-8[PubMed]
  • 61. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am. 2001; 30(2): 315-37[PubMed]
  • 62. Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010; 123(2): 183 e1-9[DOI][PubMed]
  • 63. Munteis E, Cano JF, Flores JA, Martinez-Rodriguez JE, Miret M, Roquer J. Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. Eur J Neurol. 2007; 14(9): 1048-52[DOI][PubMed]
  • 64. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995; 12(7): 622-7[PubMed]
  • 65. Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003; 26(4): 1181-5[PubMed]
  • 66. Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, et al. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care. 2005; 28(4): 850-5[PubMed]
  • 67. Severinski S, Banac S, Severinski NS, Ahel V, Cvijovic K. Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Coll Antropol. 2009; 33(1): 273-9[PubMed]
  • 68. Dretzke J, Cummins C, Sandercock J, Fry-Smith A, Barrett T, Burls A. Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. Health Technol Assess. 2004; 8(22)[PubMed]
  • 69. Consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents. 2000;
  • 70. Owers AC. Harrison's principles of internal medicine. 2008; : 2275-304
  • 71. Lorini R, d'Annunzio G, Vitali L, Scaramuzza A. IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab. 1996; 9 Suppl 1: 89-94[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments